TürkiyeResearch and clinical trials
Hemophilia gene therapy in Türkiye: 46 patients treated in clinical trials
Based on a single news source or an institutional announcement. The level of scientific evidence is low; check the details with a doctor.
According to the Federation of Hemophilia Associations, 46 hemophilia patients in Türkiye received gene therapy in clinical trials. This information was part of the federation's assessment from early 2025. At Ege University, 29 patients were treated. In 26 of them, the need for preventive factor treatment disappeared. According to the report, companies stopped investing. For this reason, hemophilia A programs were suspended. One hemophilia B project is still ongoing.
What does it mean for patients and families?
In Türkiye, gene therapy is currently possible only through limited clinical trials. You can ask your hemophilia center about eligibility.
Source
The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).
This page is translated from the Turkish original.
Related disease: Hemophilia (A and B)
This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.